The impact of GLP-1 medications on weight loss is undeniable, but emerging research suggests the results may only be temporary. A growing body of evidence shows that when patients stop taking GLP-1 ...

Fractyl Health Inc. (NASDAQ:GUTS) is one of the best biotech penny stocks to buy according to analysts. On December 2, Fractyl Health announced positive six-month results from its open-label REVEAL-1 ...

Though post-apocalyptic stories have become an expectation in the film and TV industry, Vice Gilligan‘s 2025 sci-fi, Pluribus, pushes the boundaries. Set in his favorite setting, Albuquerque, New ...

Share on Pinterest A new study observed that people taking GLP-1 drugs had improved asthma symptoms. Felix Hörhager/picture alliance via Getty Images Researchers based in the United Kingdom recently ...

After three years, only about 1 in 12 individuals taking GLP-1s to treat obesity remained on the therapy, according to a Prime Therapeutics study published on June 25. Prime is owned by 19 Blue Cross ...

BARCELONA -- A rheumatology trainee who went on TikTok to find information on her own condition may have uncovered a novel and possibly tectonic approach to treating fibromyalgia, her presentation ...

Elizabeth Cooney is a cardiovascular disease reporter at STAT, covering heart, stroke, and metabolic conditions. You can reach Liz on Signal at LizC.22. People with diabetes who were taking GLP-1 ...

Another win for the jab. GLP-1 drugs like Ozempic and Wegovy have been linked to a host of benefits beyond diabetes management and weight loss, from reduced dementia risk to addiction treatment. Now ...

Talk about a lucky charm. Drugs like Ozempic — which mimic the appetite-suppressing GLP-1 hormone the body naturally produces after eating — have been shown to spur weight loss as well as ease knee ...

Aon researchers found that within two years, improved health outcomes for patients who were taking GLP-1 drugs lowers the growth rate of medical care costs. Aon looked at medical claims data for ...